{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:02:54Z","timestamp":1781067774252,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jnma.2025.11.010","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T05:48:40Z","timestamp":1763272120000},"page":"149-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and demographic patterns of neutropenia in clozapine-treated patients with schizophrenia: A 20-year retrospective cohort study"],"prefix":"10.1016","volume":"118","author":[{"given":"Sumaiya","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3472-013X","authenticated-orcid":false,"given":"Elizabeth","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mekdem","family":"Bisrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyosi","family":"Falegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Hemphill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0136-9305","authenticated-orcid":false,"given":"Aaron","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3707-544X","authenticated-orcid":false,"given":"Rawan","family":"Elkomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrawit","family":"Zinabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-4650","authenticated-orcid":false,"given":"Miriam","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnma.2025.11.010_bib0001","unstructured":"Haidary, A.M., & Padhy, R.K. (2023). Clozapine. In StatPearls. StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535399\/"},{"key":"10.1016\/j.jnma.2025.11.010_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2018.08.016","article-title":"Treatment-resistant schizophrenia: clinical, biological, and therapeutic perspectives","volume":"131","author":"Nucifora","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.jnma.2025.11.010_bib0003","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.jnma.2025.11.010_bib0004","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40267-023-00982-6","article-title":"Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management","volume":"39","author":"Fenton","year":"2023","journal-title":"Drugs Ther Perspect"},{"issue":"2","key":"10.1016\/j.jnma.2025.11.010_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/acps.12898","article-title":"Meta-analysis examining the epidemiology of clozapine-associated neutropenia","volume":"138","author":"Myles","year":"2018","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.jnma.2025.11.010_bib0006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.169.4.483","article-title":"Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland","volume":"169","author":"Atkin","year":"1996","journal-title":"Br J Psychiatry"},{"issue":"12","key":"10.1016\/j.jnma.2025.11.010_bib0007","first-page":"1131","article-title":"Genetics of clozapine-associated neutropenia","volume":"18","author":"Legge","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"9","key":"10.1016\/j.jnma.2025.11.010_bib0008","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jnma.2025.11.010_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MOH.0000000000000391","article-title":"Clozapine-induced agranulocytosis\/granulocytopenia: mechanisms and monitoring","volume":"25","author":"Wici\u0144ski","year":"2018","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"10.1016\/j.jnma.2025.11.010_bib0010","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00277-020-04215-y","article-title":"Clozapine-induced agranulocytosis","volume":"99","author":"Mijovic","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jnma.2025.11.010_bib0011","article-title":"TriNetX Research Network: real-world evidence generation platform","year":"2024","journal-title":"TriNetX LLC"},{"issue":"10","key":"10.1016\/j.jnma.2025.11.010_bib0012","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.jnma.2025.11.010_bib0013","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"2001","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.jnma.2025.11.010_bib0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/lc.1999.v133.a94931","article-title":"Benign ethnic neutropenia: what is a normal absolute neutrophil count?","volume":"133","author":"Haddy","year":"1999","journal-title":"J Lab Clin Med"},{"issue":"4","key":"10.1016\/j.jnma.2025.11.010_bib0015","first-page":"536","article-title":"Agranulocytosis with antithyroid drugs: a case report and review of monitoring strategies","volume":"61","author":"Fredette","year":"2021","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jnma.2025.11.010_bib0016","first-page":"E210","article-title":"Consensus statement on the use of clozapine during the COVID-19 pandemic","volume":"46","author":"Siskind","year":"2021","journal-title":"J Psychiatry Neurosci"},{"issue":"5","key":"10.1016\/j.jnma.2025.11.010_bib0017","first-page":"485","article-title":"Identifying genetic risk factors for clozapine-induced agranulocytosis using polygenic risk scores","volume":"17","author":"Legge","year":"2017","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jnma.2025.11.010_bib0018","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-244X-14-102","article-title":"Clozapine: a review of clinical practice guidelines and prescribing trends","volume":"14","author":"Warnez","year":"2014","journal-title":"BMC Psychiatry"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968425003438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968425003438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:53:45Z","timestamp":1781067225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968425003438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0027968425003438"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2025.11.010","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and demographic patterns of neutropenia in clozapine-treated patients with schizophrenia: A 20-year retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2025.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Medical Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}